Role of antibodies reactive to HspX in discriminating pulmonary tuberculosis contacts with high risk of developing active disease

Brazilian Journal of Infectious Diseases

Volumn 15, Issue 6, 2011, Pages 617-618

  dos Reis, Michelle Cristina Guerreiro ^a   de Souza Silva, Bruna Daniella ^a   de Sousa, Eduardo Martins ^a   Junqueira Kipnis, Ana Paula ^a  

^a FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; HSPX ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ANTIBODY DETECTION; ANTIGEN ANTIBODY REACTION; CLINICAL ARTICLE; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; INFECTION PREVENTION; INFECTION RISK; LETTER; LUNG TUBERCULOSIS; MALE; RISK ASSESSMENT; TUBERCULIN TEST;

ANTIBIOTIC PROPHYLAXIS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; CONTACT TRACING; HUMANS; ISONIAZID; MYCOBACTERIUM TUBERCULOSIS; RISK FACTORS; TUBERCULIN TEST; TUBERCULOSIS, PULMONARY;

EID: 84855950059     PISSN: 14138670     EISSN: 16784391     Source Type: Journal    
DOI: 10.1016/S1413-8670(11)70263-X     Document Type: Letter

References (5)

1. WHO. Global Tuberculosis Control, a short update to 2009 report. WHO, 2009. []. http://www.who.int/tb/publications/global_report/2009/update/en/index.html.
2. Pineda N.I.S., Pereira S.M., Matos E.D., et al. Chemoprophylaxis in the prevention of tuberculosis. J Bras Pneumol 2003, 342:268-272.
3. Rabahi M.F., Junqueira-Kipnis A.P., Reis M.C.G., et al. Humoral response to Hspx and GlcB to previous and recent infection by Mycobacterium tuberculosis. BMC Infect Dis 2007, 31(7):148.
4. Casadevall A., Pirofski L. Antibody-mediated regulation of cellular immunity and the inflammatory response. Trends Immunol 2003, 24(9):474-478.
5. Maertzdorf J., Repsilber D., Parida S.K., et al. Human gene expression profiles of susceptibility and resistance in tuberculosis. Genes Immun 2011, 12(1):15-22.